Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jordan Karlitz

Concepts (158)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
37
2026
874
8.390
Why?
Early Detection of Cancer
27
2026
506
6.190
Why?
Colonoscopy
18
2026
257
3.830
Why?
Feces
13
2026
496
2.800
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
5
2021
42
2.670
Why?
Patient Compliance
12
2026
589
2.230
Why?
Adenocarcinoma
7
2024
927
2.140
Why?
Carcinoid Tumor
3
2022
21
2.050
Why?
Colonic Neoplasms
5
2022
259
1.100
Why?
Mass Screening
10
2026
1307
1.080
Why?
Occult Blood
7
2026
41
1.020
Why?
Telemedicine
3
2021
966
1.010
Why?
DNA
3
2026
1421
0.890
Why?
Genetic Testing
2
2018
492
0.790
Why?
Appendiceal Neoplasms
1
2022
28
0.730
Why?
SEER Program
7
2022
233
0.710
Why?
Incidence
9
2024
2936
0.700
Why?
DNA, Neoplasm
3
2026
160
0.680
Why?
Immunohistochemistry
5
2021
1712
0.680
Why?
United States
22
2026
16136
0.680
Why?
Adenoma
2
2021
210
0.670
Why?
Disease Transmission, Infectious
1
2020
69
0.610
Why?
Microsatellite Instability
2
2018
57
0.560
Why?
Colonic Polyps
1
2020
87
0.560
Why?
Middle Aged
28
2026
36619
0.550
Why?
Health Status Disparities
2
2020
322
0.530
Why?
Humans
52
2026
146342
0.520
Why?
Betacoronavirus
1
2020
288
0.510
Why?
Practice Patterns, Physicians'
2
2018
1408
0.490
Why?
Age of Onset
5
2022
558
0.470
Why?
Colectomy
2
2015
119
0.460
Why?
Pneumonia, Viral
1
2020
387
0.440
Why?
Coronavirus Infections
1
2020
379
0.440
Why?
Family
1
2020
690
0.440
Why?
Male
29
2026
73396
0.420
Why?
Follow-Up Studies
8
2026
5439
0.410
Why?
Retrospective Studies
13
2026
17438
0.400
Why?
Rectal Neoplasms
3
2021
160
0.390
Why?
Age Factors
6
2022
3347
0.390
Why?
Colorectal Surgery
1
2013
32
0.390
Why?
Female
29
2026
79499
0.380
Why?
Aged
18
2026
26432
0.350
Why?
Pandemics
1
2020
1707
0.340
Why?
Immunocompetence
1
2010
46
0.320
Why?
Medicare
4
2026
920
0.310
Why?
Germ-Line Mutation
2
2021
180
0.310
Why?
Herpesvirus 4, Human
1
2010
172
0.300
Why?
Adult
17
2022
41087
0.290
Why?
Louisiana
2
2021
30
0.280
Why?
Risk Assessment
4
2022
3712
0.280
Why?
Colitis
1
2010
283
0.260
Why?
Cross-Sectional Studies
4
2025
5899
0.260
Why?
Carcinoma
2
2021
225
0.240
Why?
Immunochemistry
1
2026
12
0.240
Why?
Uterine Diseases
1
2006
18
0.240
Why?
Proto-Oncogene Proteins p21(ras)
2
2017
250
0.240
Why?
Colonic Diseases
1
2006
39
0.240
Why?
Inflammatory Bowel Diseases
1
2010
352
0.230
Why?
Endometriosis
1
2006
58
0.230
Why?
Cost Sharing
1
2025
23
0.230
Why?
Cost-Benefit Analysis
3
2026
640
0.220
Why?
Risk Factors
6
2022
10921
0.220
Why?
Neoplasm Staging
4
2022
1488
0.210
Why?
Health Services Accessibility
2
2025
1107
0.200
Why?
Appendectomy
1
2022
93
0.180
Why?
MutL Protein Homolog 1
1
2021
11
0.170
Why?
Adenomatous Polyposis Coli Protein
1
2021
20
0.170
Why?
Rural Population
2
2018
677
0.170
Why?
DNA Mismatch Repair
1
2021
54
0.170
Why?
Forecasting
2
2020
388
0.160
Why?
Clinical Competence
1
2009
1272
0.160
Why?
Mutation, Missense
1
2021
334
0.150
Why?
Diagnosis, Differential
2
2016
1503
0.140
Why?
Pathologists
1
2018
19
0.140
Why?
Gastroenterologists
1
2018
21
0.140
Why?
Delivery of Health Care
1
2025
947
0.140
Why?
Lymph Nodes
2
2014
511
0.130
Why?
Insurance, Health
1
2020
318
0.130
Why?
Congresses as Topic
1
2019
226
0.130
Why?
Organizational Objectives
1
2017
67
0.130
Why?
Medicaid
1
2021
477
0.130
Why?
Physician's Role
1
2018
225
0.120
Why?
DNA Mutational Analysis
1
2017
410
0.120
Why?
Feasibility Studies
1
2021
1135
0.120
Why?
Neoplastic Syndromes, Hereditary
1
2016
47
0.110
Why?
Health Care Costs
1
2018
423
0.110
Why?
Physician-Patient Relations
1
2020
597
0.110
Why?
Neoplasms, Multiple Primary
1
2015
57
0.100
Why?
Preoperative Period
1
2015
157
0.100
Why?
Neoplasms, Second Primary
1
2015
103
0.100
Why?
Preoperative Care
1
2016
396
0.090
Why?
Societies, Medical
1
2017
907
0.090
Why?
Endoscopy, Gastrointestinal
2
2010
236
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1998
0.090
Why?
Urban Population
1
2015
497
0.080
Why?
Jejunal Diseases
1
2010
6
0.080
Why?
Choristoma
1
2010
20
0.080
Why?
Ribavirin
1
2010
81
0.070
Why?
Quality Improvement
1
2018
1354
0.070
Why?
Abdominal Pain
2
2010
149
0.070
Why?
Veterans
1
2021
1650
0.070
Why?
Young Adult
3
2020
14330
0.070
Why?
Interferon-alpha
1
2010
201
0.070
Why?
Pancreas
1
2010
343
0.070
Why?
Prevalence
1
2015
2861
0.060
Why?
Hepatitis C
1
2010
251
0.060
Why?
Alabama
1
2026
42
0.060
Why?
Brain Neoplasms
1
2016
1325
0.060
Why?
United States Department of Defense
1
2026
26
0.060
Why?
Hospitals, General
1
2026
23
0.060
Why?
Proportional Hazards Models
2
2021
1331
0.060
Why?
Biopsy, Needle
1
2006
183
0.060
Why?
Israel
1
2025
45
0.060
Why?
Ovariectomy
1
2006
164
0.060
Why?
Registries
1
2014
2400
0.060
Why?
Surveys and Questionnaires
1
2018
6073
0.060
Why?
Massachusetts
1
2026
178
0.060
Why?
Hysterectomy
1
2006
139
0.060
Why?
Vasculitis
1
2005
69
0.050
Why?
Polyethylene Glycols
1
2010
650
0.050
Why?
Aged, 80 and over
3
2026
8391
0.050
Why?
Brain Diseases
1
2005
159
0.050
Why?
Antiviral Agents
1
2010
779
0.050
Why?
Time Factors
1
2015
7109
0.050
Why?
California
1
2025
475
0.050
Why?
Celiac Disease
1
2005
285
0.040
Why?
Language
1
2025
315
0.040
Why?
North America
1
2022
300
0.040
Why?
Europe
1
2022
421
0.040
Why?
Chemotherapy, Adjuvant
1
2021
429
0.040
Why?
Colonography, Computed Tomographic
1
2018
8
0.040
Why?
Disease Progression
1
2006
2867
0.030
Why?
Military Personnel
1
2026
726
0.030
Why?
Mutation
2
2017
4093
0.030
Why?
Carcinoembryonic Antigen
1
2014
40
0.030
Why?
Survival Analysis
1
2017
1378
0.030
Why?
Genetic Predisposition to Disease
1
2022
2488
0.020
Why?
Sex Factors
1
2018
2107
0.020
Why?
Prognosis
1
2021
4351
0.020
Why?
Treatment Outcome
1
2006
11821
0.020
Why?
Urban Health
1
2010
95
0.020
Why?
Drug Therapy, Combination
1
2010
1036
0.020
Why?
Recombinant Proteins
1
2010
1361
0.020
Why?
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
1
2005
8
0.010
Why?
CD2 Antigens
1
2005
7
0.010
Why?
Complement C4b
1
2005
9
0.010
Why?
Infant, Newborn
1
2017
6460
0.010
Why?
Complement C1q
1
2005
33
0.010
Why?
CD3 Complex
1
2005
113
0.010
Why?
Fatal Outcome
1
2005
302
0.010
Why?
Complement C3
1
2005
195
0.010
Why?
Cohort Studies
1
2014
6077
0.010
Why?
Infant
1
2017
10114
0.010
Why?
Polymerase Chain Reaction
1
2005
1031
0.010
Why?
Child, Preschool
1
2017
11913
0.010
Why?
Peptide Fragments
1
2005
693
0.010
Why?
Adolescent
1
2017
22557
0.010
Why?
Child
1
2017
22693
0.010
Why?
Karlitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)